BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 34389918)

  • 41. A Preliminary Nuclear Magnetic Resonance Metabolomics Study Identifies Metabolites that Could Serve as Diagnostic Markers of Major Depressive Disorder.
    Badamasi IM; Maulidiani M; Lye MS; Ibrahim N; Shaari K; Stanslas J
    Curr Neuropharmacol; 2022; 20(5):965-982. PubMed ID: 34126904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Principal component directed partial least squares analysis for combining nuclear magnetic resonance and mass spectrometry data in metabolomics: application to the detection of breast cancer.
    Gu H; Pan Z; Xi B; Asiago V; Musselman B; Raftery D
    Anal Chim Acta; 2011 Feb; 686(1-2):57-63. PubMed ID: 21237308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolomic study of the fever model induced by baker's yeast and the antipyretic effects of aspirin in rats using nuclear magnetic resonance and gas chromatography-mass spectrometry.
    Zhang F; Wang D; Li X; Li Z; Chao J; Qin X
    J Pharm Biomed Anal; 2013; 81-82():168-77. PubMed ID: 23670098
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NMR metabolomics study of follicular fluid in women with cancer resorting to fertility preservation.
    Castiglione Morelli MA; Iuliano A; Schettini SCA; Petruzzi D; Ferri A; Colucci P; Viggiani L; Cuviello F; Ostuni A
    J Assist Reprod Genet; 2018 Nov; 35(11):2063-2070. PubMed ID: 30069850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics.
    Wei Y; Jasbi P; Shi X; Turner C; Hrovat J; Liu L; Rabena Y; Porter P; Gu H
    J Proteome Res; 2021 Jun; 20(6):3124-3133. PubMed ID: 34033488
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry.
    Wu H; Xue R; Lu C; Deng C; Liu T; Zeng H; Wang Q; Shen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3111-7. PubMed ID: 19716777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers.
    Woo HM; Kim KM; Choi MH; Jung BH; Lee J; Kong G; Nam SJ; Kim S; Bai SW; Chung BC
    Clin Chim Acta; 2009 Feb; 400(1-2):63-9. PubMed ID: 19010317
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine.
    Carrola J; Rocha CM; Barros AS; Gil AM; Goodfellow BJ; Carreira IM; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
    J Proteome Res; 2011 Jan; 10(1):221-30. PubMed ID: 21058631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted and untargeted urinary metabolic profiling of bladder cancer.
    Ossoliński K; Ruman T; Copié V; Tripet BP; Kołodziej A; Płaza-Altamer A; Ossolińska A; Ossoliński T; Nieczaj A; Nizioł J
    J Pharm Biomed Anal; 2023 Sep; 233():115473. PubMed ID: 37229797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
    Di Giovanni N; Meuwis MA; Louis E; Focant JF
    Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
    Struck-Lewicka W; Kordalewska M; Bujak R; Yumba Mpanga A; Markuszewski M; Jacyna J; Matuszewski M; Kaliszan R; Markuszewski MJ
    J Pharm Biomed Anal; 2015; 111():351-61. PubMed ID: 25684700
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy.
    Law WS; Huang PY; Ong ES; Ong CN; Li SF; Pasikanti KK; Chan EC
    Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2436-46. PubMed ID: 18634125
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder.
    Chen JJ; Liu Z; Fan SH; Yang DY; Zheng P; Shao WH; Qi ZG; Xu XJ; Li Q; Mu J; Yang YT; Xie P
    Sci Rep; 2014 Jul; 4():5855. PubMed ID: 25068480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
    Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
    [No Abstract]   [Full Text] [Related]  

  • 55. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
    Liang Q; Wang C; Li B
    Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum Metabolomic Profiles for Breast Cancer Diagnosis, Grading and Staging by Gas Chromatography-Mass Spectrometry.
    Hadi NI; Jamal Q; Iqbal A; Shaikh F; Somroo S; Musharraf SG
    Sci Rep; 2017 May; 7(1):1715. PubMed ID: 28496143
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Absolute quantification of choline-related biomarkers in breast cancer biopsies by liquid chromatography electrospray ionization mass spectrometry.
    Mimmi MC; Finato N; Pizzolato G; Beltrami CA; Fogolari F; Corazza A; Esposito G
    Anal Cell Pathol (Amst); 2013; 36(3-4):71-83. PubMed ID: 24036926
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gas chromatography/flame ionisation detection mass spectrometry for the detection of endogenous urine metabolites for metabonomic studies and its use as a complementary tool to nuclear magnetic resonance spectroscopy.
    Fancy SA; Beckonert O; Darbon G; Yabsley W; Walley R; Baker D; Perkins GL; Pullen FS; Rumpel K
    Rapid Commun Mass Spectrom; 2006; 20(15):2271-80. PubMed ID: 16810707
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urinary metabolomics for discovering metabolic biomarkers of bladder cancer by UPLC-MS.
    Wang R; Kang H; Zhang X; Nie Q; Wang H; Wang C; Zhou S
    BMC Cancer; 2022 Feb; 22(1):214. PubMed ID: 35220945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A quantitative multimodal metabolomic assay for colorectal cancer.
    Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
    BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.